Skip to main content
Divisions
Molecular diagnostics and distributed qPCR solutions.
Complete PCR solutions for molecular diagnostics.
Customised NGS for next-generation molecular insights.
Technologies
Instruments
Miniaturised qPCR devices with superior performance
Software Solutions
Cloud-based platform driven by artificial intelligence for advanced operations
Reagents
Deep multiplexing solutions and innovative reagents for all use cases
About us
Vision & Values
Our identity and the principles that guide the Group.
Numbers and Certifications
Reliability, performance and standards that define our work.
Leadership
The management team leading Helyx Industries.
About Helyx
The history, evolution and culture of our Group.
Insights
See all Insights
31 July 2026 | Distributed Diagnostics
Circular Health: when distributed diagnostics closes the loop between environment and health
A distributed molecular network supports Circular Health when it preserves quality and comparability from sampling to decision-making and verifies the effects of action.
24 July 2026 | Biotech and Diagnostic Innovation
Ambient-stable multiplex PCR: when stability becomes system architecture
Ambient-stable multiplex PCR can improve logistics when formulation, packaging, reconstitution and performance at the end of shelf life are validated together in the real-world workflow.
News
Press releases
10 July 2026
Global Corporate Finance LLC sottoscrive la seconda tranche di aumento di capitale in esecuzione dell’accordo di investimento sottoscritto in data 31 luglio 2025
Press releases
30 June 2026
"Warrant Helyx Industries S.p.A. 2021-2026": risultati del nono periodo di esercizio
Updates and announcements
24 June 2026
Helyx Industries in the public hospital channel: two awards in oncohematology
Updates and announcements
08 June 2026
Subsidiary Hyris awarded a public tender in Spain for the supply of SARS-CoV-2 cellular-immunity kits within a public research project
Investors
Helyx Industries is an industrial group active in the field of genetics. It has proprietary technologies and processes for complete and integrated solutions in molecular biology, from PCR to NGS. Through its divisions, it offers its solutions directly to diagnostic laboratories and hospitals or provides its services to diagnostic and industrial partners. Helyx Industries is listed on Euronext Growth in Milan.
Read more
Contact us
IT
EN
IT
EN
Divisions
Molecular diagnostics and distributed qPCR solutions.
Hyris System™
Agrifood & Nutraceuticals Catalogue
Development and OEM services
Complete PCR solutions for molecular diagnostics.
Human Health Catalogue
Customised NGS for next-generation molecular insights.
Customised NGS panels
Compatible areas & technologies
Technologies
Instruments
Miniaturised qPCR devices with superior performance
bCUBE™
bGATE™
Software Solutions
Cloud-based platform driven by artificial intelligence for advanced operations
bAPP™
Reagents
Deep multiplexing solutions and innovative reagents for all use cases
Sagitta™
Stable multiplex reagents
About Us
Vision & Values
Our identity and the principles that guide the Group.
Vision
Mission
Numbers and Certifications
Reliability, performance and standards that define our work.
Facts and Figures
Certifications
Leadership
The management team leading Helyx Industries.
People
About Helyx
The history, evolution and culture of our Group.
Our History
Timeline
Insights
News
Updates & announcements
Commercial news announced by Helyx Industries.
Read all
Press releases
Regulated and price-sensitive press releases.
Read all
Scientific Publications
Research, studies and published scientific papers.
Read all
Investors
Helyx Industries
Helyx Industries is an integrated biotech group with proprietary technologies that develops diagnostic solutions, focusing on public health, distributed diagnostics and molecular innovation.
Download Pitch Deck
Overview
Corporate Governance
Information for shareholders
Financial data
Press releases
Financial calendar
Shareholders' meeting
Analyst Coverage
Warrant
Internal dealing
Investment Agreement with GCF
Concluded extraordinary transactions
IPO
Investor Relations Contacts
Contacts
All Posts in
Biotech and Diagnostic Innovation
24 July 2026
ID03 - Ambient-stable multiplex PCR: when stability becomes system architecture
04 March 2026
ID08 - Epidemiological surveillance and distributed PCR
17 November 2025
ID02 - Multiplex PCR Diagnosis for HPV: New Frontiers
01 August 2025
ID04 - Decentralised Real-Time PCR for respiratory diseases
01 July 2025
ID15 - The Helyx Industries Ecosystem: the Hyris System™ modular diagnostic platform
20 June 2025
ID05 - Cloud Diagnostics Analytics: trends and applications
10 May 2025
ID01 - Artificial intelligence in PCR diagnostics
20 April 2025
ID06 - What is PCR - Fundamentals of molecular biology
Back to News Frontpage
